These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 3258912

  • 1. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A, Tanda G, Frau R, Di Chiara G.
    J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
    [Abstract] [Full Text] [Related]

  • 2. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR, Napier TC, Mueller RA.
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [Abstract] [Full Text] [Related]

  • 3. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.
    Maura G, Giardi A, Raiteri M.
    J Pharmacol Exp Ther; 1988 Nov; 247(2):680-4. PubMed ID: 2903237
    [Abstract] [Full Text] [Related]

  • 4. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol.
    Imperato A, Di Chiara G.
    J Pharmacol Exp Ther; 1986 Oct; 239(1):219-28. PubMed ID: 3761194
    [Abstract] [Full Text] [Related]

  • 5. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y, Fage D, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [Abstract] [Full Text] [Related]

  • 6. Effects of specific D-1 and D-2 dopamine agonists (LY141865 and SKF-38393) and pergolide on urinary output of rats.
    Leander JD.
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):290-5. PubMed ID: 2962555
    [Abstract] [Full Text] [Related]

  • 7. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.
    Arnt J, Hyttel J.
    Psychopharmacology (Berl); 1985 Oct; 85(3):346-52. PubMed ID: 2860689
    [Abstract] [Full Text] [Related]

  • 8. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J.
    Eur J Pharmacol; 1985 Jul 11; 113(1):79-88. PubMed ID: 2931283
    [Abstract] [Full Text] [Related]

  • 9. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T, Sharp T, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 11; 334(2):117-24. PubMed ID: 2946964
    [Abstract] [Full Text] [Related]

  • 10. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis.
    Imperato A, Di Chiara G.
    Eur J Pharmacol; 1988 Nov 08; 156(3):385-93. PubMed ID: 2905668
    [Abstract] [Full Text] [Related]

  • 11. Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.
    Bijak M, Danek L, Smiałowski A.
    Pol J Pharmacol Pharm; 1988 Nov 08; 40(5):535-41. PubMed ID: 2908137
    [Abstract] [Full Text] [Related]

  • 12. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M, White FJ.
    Synapse; 1989 Nov 08; 4(4):267-80. PubMed ID: 2603146
    [Abstract] [Full Text] [Related]

  • 13. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May 08; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 14. Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats.
    Longoni R, Spina L, Di Chiara G.
    Life Sci; 1987 Nov 02; 41(18):2135-45. PubMed ID: 2959833
    [Abstract] [Full Text] [Related]

  • 15. Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation.
    Martin GE, Bendesky RJ.
    J Pharmacol Exp Ther; 1984 Jun 02; 229(3):706-11. PubMed ID: 6144790
    [Abstract] [Full Text] [Related]

  • 16. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May 02; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 17. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
    Carlson JH, Bergstrom DA, Weick BG, Walters JR.
    Synapse; 1987 May 02; 1(5):411-6. PubMed ID: 2975067
    [Abstract] [Full Text] [Related]

  • 18. Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.
    Wang L, Pitts DK.
    J Pharmacol Exp Ther; 1995 Jan 02; 272(1):164-76. PubMed ID: 7815330
    [Abstract] [Full Text] [Related]

  • 19. Microiontophoretic studies of the effects of D-1 and D-2 receptor agonists on type I caudate nucleus neurons: lack of synergistic interaction.
    Shen RY, Asdourian D, Chiodo LA.
    Synapse; 1992 Aug 02; 11(4):319-29. PubMed ID: 1354398
    [Abstract] [Full Text] [Related]

  • 20. SCH 23390 antagonizes apomorphine- and ergot-induced hypothermia.
    Carboni E, Longoni R, Deidda S, Di Chiara G.
    Eur J Pharmacol; 1986 Jun 05; 125(1):17-22. PubMed ID: 3525197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.